ADPT's Advanced Deterministic Scorecard reveals severe financial health concerns: a Piotroski F-Score of 1/9 indicates extreme weakness, with no positive signals in profitability, cash flow, or leverage management. The Altman Z-Score is unavailable, but the company's negative ROE (-27.82%), negative operating margin (-17.82%), and high debt/equity (0.93) suggest significant distress risk. Despite strong revenue growth (51% YoY) and a history of earnings surprises, the stock trades at a forward P/E of -48.78, reflecting deep losses and speculative valuation. Insider selling totaling $12.73M in six months further undermines confidence, signaling potential internal skepticism about near-term prospects.